MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z

Racial and Geographic Disparities in Parkinson’s Disease Patients with Gastrostomy Feeding Tube Placement

D. Kim, Z. Kunicki, R. Jones, A. D'Abreu, J. Friedman, U. Akbar (Providence, RI, USA)
Randomized, placebo-controlled study investigating the safety, pharmacokinetics and efficacy of inhaled apomorphine in Parkinson’s disease patients

E. Thijssen, J. den Heijer, D. Puibert, M. Lei, D. Hasegawa, K. Keum, K. Mochel, P. Roset, E. van Brummelen, T. Naranda, G. Groeneveld (Leiden, Netherlands)
Rapid on-time onset and sustained improvements in motor states throughout the day following treatment with levodopa/carbidopa intestinal gel (LCIG) vs immediate-release levodopa/carbidopa oral capsules (LCIR)

R. Pahwa, J. Aldred, N. Gupta, E. Terasawa, V. Garcia Horton, D. Macaulay, P. Kandukuri, Y. Jalundhwala, Y. Bao, P. Kukreja, S. Isaacson (Kansas City, KS, USA)
Rare variants of the LRRK2 gene in the haplotype as one of the potential risk factors for endemic parkinsonism in a small isolated region in the Czech Republic

P. Kaňovský, K. Kolaříková, R. Vodička, R. Vrtěl, K. Menšíková, T. Bartoníková, M. Procházka (Olomouc, Czech Republic)
Rate of Neuromuscular Excitation during Cycling Related to Mobility in Parkinson’s Disease

R. Daniels, C. Knight (Newark, DE, USA)
Rates of Pharmacological Treatment of Neuropsychiatric Symptoms in Early Parkinson’s Disease

C. Kulick-Soper, C. Caspell-Garcia, C. Coffey, M. Picillo, D. Weintraub, N. Dahodwala (Philadelphia, PA, USA)
RBD and autonomic dysfunction in newly diagnosed Parkinson’s disease patients

G.M Riboldi, L. Pan, K. dePaiva Lopes, K. Watkins, T. Raj, U. Kang (New York, NY, USA)
Real Time Quality Control for Subjective Endpoints in Clinical Trials

Y. Peng, G. Morinan, J. O'Keeffe (London, United Kingdom)
Real World Clinical Outcomes Using a Novel Directional Lead from a Multicenter Registry of Deep Brain Stimulation for Parkinson’s Disease

G. Deuschl, R. Jain, H. Scholtes, A. Wang, S. Paschen, M. Barbe, A. Kühn, M. Pötter-Nerger, J. Volkmann, J. Vesper (Kiel, Germany)
Real-World Data on the Use of Levodopa-Carbidopa Intestinal Gel in Patients with Advanced Parkinson’s Disease who are Treated with Deep Brain Stimulation: The PD-DUAL Study

J. Aldred, F. Amjad, A. Johnson, P. Kukreja, I. Malaty, S. Parashos, J. Siddiqui, M. Siddiqui, J. Zamudio, S. Thakkar (Spokane, WA, USA)
Real-World Deutetrabenazine Dosing Patterns in Patients With Huntington’s Disease or Tardive Dyskinesia

R. Ayyagari, A. Wilhelm, J. Alexander, N. Chaijale, V. Garcia-Horton, F. Devine, B. Carroll (Boston, MA, USA)
Real-World Evaluation of Patient Characteristics and Disease Management in Long-Term Valbenazine Treatment in Adults with Tardive Dyskinesia

E. Goldberg, C. Yonan, N. Longo, H. Cratty, M. Nicosia, J. Sampalis, T. Carmack, S. Siegert, A. Angelov (San Diego, CA, USA)
Real-World Evidence for a Smartwatch-based Parkinson’s Motor Assessment App in Patients Undergoing Therapy Changes

A. Hadley, D. Riley, D. Heldman (Cleveland, OH, USA)
Real-world evidence for symptomatic relief in essential tremor using transcutaneous afferent patterned stimulation therapy

R. Dhall, W. Ondo, M. Petrossian, R. Pahwa, M. Lew, S. Shin, P. Chidester, A. Rajagopal, M. Gupta, K. Rosenbluth, S. Isaacson (Little Rock, AR, USA)
Real-world Evidence of Directional DBS Programming in Parkinson’s disease and Essential Tremor: The Cleveland Clinic Experience

B. Walter, S. Ozinga, S. Pallavaram, B. Cheeran, R. Rammo, E. Hennigs, J. Scott, K. Wilson, E. Walter, A. Machado, S. Nagel (Austin, TX, USA)
Real-World Healthcare Resource Utilization in Patients with Parkinson’s Disease and Motor Fluctuations

M. Serbin, S. Odak, C. Macahilig, N. Joshi, A. Shah, X. Ng, K. Olson, G. Liang, O. Klepitskaya, C. Yonan (San Diego, CA, USA)
Real-World Use and Impact of VMAT2 Inhibitors in Patients with Tardive Dyskinesia

L. Lundt, E. Franey, C. Yonan (San Diego, CA, USA)
Recent Clinical variation of Segawa Disease in Japan

K. Hoshino, K. Kimura, Y. Nagao, M. Fukumizu, H. Fukutda, M. Nozaki, M. Hayashi, I. Kawahata (Tokyo, Japan)
Recent Trends in Complications after Deep Brain Stimulation Implantation: Insights from Big Data Analysis

W. Hamel, M. Pötter-Nerger, R. Agarwal, A. Connolly, S. Rosenberg, B. Cheeran, A. Sharan (Hamburg, Germany)
Recessive CWF19L1 mutations in a family with dystonia-ataxia syndrome

S. Weber, M. Zech, S. Boesch, J. Winkelmann (Kassel, Germany)
Reclassification of variant c.5825C>T and clinical evidence of variant c.3955_3958dup in a Peruvian family with ATM syndrome

M. Cornejo-Olivas, R. Rodriguez, J. Bazalar-Montoya, E. Sarapura-Castro, M. Torres-Loarte, A.A Rivera-Valdivia, Y. Sullcahuaman-Allende (Lima, Peru)
Red blood cells alpha-synuclein heteroaggregates in the differential diagnosis of Lewy body dementias, Alzheimer’s disease and healthy controls

G. Palermo, L. Giampietri, S. Daniele, R. Piccarducci, D. Frosini, G. Tognoni, U. Bonuccelli, C. Martini, F. Baldacci, R. Ceravolo (Pisa, Italy)
Reduced Striatal VMAT2 in REM Sleep Behavior Disorder: A Gateway to Preclinical Parkinson’s Disease

K. Barnham, L. Beauchamp, V. Villemagne, D. Finnkelstein, V. Dore, A. Bush, C. Rowe (Melbourne, Australia)
Reduction of OFF time with apomorphine infusion during hours of pump use: Analysis from a Phase III, open-label study

S. Isaacson, A. Espay, R. Pahwa, T. Clinch, P. LeWitt (Boca Raton, FL, USA)
Refining Knowledge on the Treatment of Pisa Syndrome with Botulinum Toxin

C.A Artusi, F. Marchet, U. Dimanico, C. Zanella, M. Zibetti, A. Merola, G. Massazza, L. Lopiano (Torino, Italy)
Refractory cervical dystonia: is the infiltration of the obliquus capitis inferior muscle a game changer?

A. Beltrán, F. Rodríguez, J.L Chico García, P. Parra, I. Pareés, J.C Martínez Castrillo, A. Alonso Cánovas, G. Sánchez (Madrid, Spain)
Refractory tremor: is perampanel a potentially useful therapy?

Á. Beltrán, F. Rodríguez, J.L Chico, P. Parra, I. Pareés, J.C Martínez Castrillo, A. Alonso Cánovas (Madrid, Spain)
Regional cortical thickness alterations in PD patients with cognitive impairment

V. Goyal, S. Chaudhary, A. Ankeeta, S. Kumaran, P. Bhat (New Delhi, India)
Regional free-water differentially associated with glial activation, neuroinflammation, and neurodegeneration in de novo Parkinson’s disease

D. Tosun, R. Ellis (San Francisco, CA, USA)
Regional, Not Global, Functional Connectivity Contributes to Isolated Focal Dystonia

S. Norris, A. Morris, M. Campbell, M. Karimi, A. Babatunde, R. Paniello, A. Snyder, J. Mink, J. Perlmutter (St. Louis, MO, USA)
Relationship Between a-syn RT-QuIC and a-syn Neuropathologic Burden in Dementia with Lewy Bodies

D. Coughlin, C. Orru, B. Groveman, A. Hiniker, R. Rissman, B. Caughey, D. Galasko (San Diego, CA, USA)
Relationship between REM sleep without atonia and sleep architecture in multiple system atrophy

Y. Saitoh, M. Miyazaki, A. Tsuru, Y. Takahashi (Kodaira, Tokyo, Japan)
Relationship between tumor and very slow Parkinson`s disease progression

H. Mori (Kurashiki, Okayama, Japan)
Reliability and Stability of Programming Directional Deep Brain Stimulation

J. Karl, C. Gill, J. Joyce, B. Ouyang, L. Verhagen Metman (Chicago, IL, USA)
Remote and frequent assessment of Huntington’s disease in clinical trials: Strategies for assessing and accounting for the practice effect

A. Wolfer, F. Lipsmeier, R. Tortelli, F.B Rodrigues, L.M Byrne, C. Simillion, T. Kilchenmann, A. Bamdadian, S.A Schobel, E.J Wild, M. Lindemann (Basel, Switzerland)
Remote monitoring of physical activity and falls in patients with Huntington’s disease using wearable sensors

J. Adams, R. Dorsey, E. Waddell, M. Coffey, C. Tarolli, R. Schneider, M. Zahiri, A. Varizi, H. Nguyen (Rochester, NY, USA)
Remote monitoring of physical activity in Veterans with Parkinson’s disease

K. Waddell, S. Wood, S. Koganti, J. Morley (Philadelphia, PA, USA)
Remote video-based research visits in a phase 3 clinical trial in Parkinson’s disease

C. Tarolli, K. Andrzejewski, G. Zimmerman, M. Bull, S. Goldenthal, P. Auinger, E.R Dorsey, K. Biglan, T. Simuni (Rochester, NY, USA)
Remotely-monitored home-based physiotherapy is feasible for both people with Parkinson’s disease and physiotherapists

A. Flynn, E. Preston, S. Dennis, C. Canning, N. Allen (Bruce, Australia)
Repetitive transcranial magnetic stimulation (rTMS) fails to improve cognition in patients with Parkinson’s disease: a meta-analysis of randomized controlled trials

P. He, L. Wang, J. Chen, Y. Zhang, Y. Gao, Q. Xu, Y. Qiu, H. Cai, Y. Li, Z. Huang, S. Feng, J. Zhao, G. Ma, K. Nie, L. Wang (Guangzhou, China)
Researches on the correlation between wearable device data and UPDRS scores in patients with Parkinson’s disease

B.o Shen (Nanjing, China)
Resistance Training on Postural Control in Parkinson’s Disease: a Randomized Controlled Trial

C. Souza, J. Chen, D. Francato, A. Barbosa, M. Voos, E. Barbosa, H. Chien (Sao Paulo, Brazil)
Resource patients involved in a program of therapeutic education of patients with Parkinson’s disease: contribution to patients’ recruitment

A.L Ramelli, M.L Fouquet, S. Vasa, P. Simoni, S. Stefanizzi, A. Petit, H. Salhi, G. Fénelon, P.h Remy (Creteil, France)
Respiratory training in Parkinson’s disease: a systematic review

M. Nijkrake, V. van Dongen, P. Wees, B. Bloem, H. Kalf (Nijmegen, Netherlands)
Resting State Functional and Structural Connectivity Changes of Cerebellum Basal Ganglia Interconnecting Network in Parkinson’s Disease

V. Radhakrishnan, S. Krishnan, B. Thomas, C. Gallea, C. Kesavadas, A. Kishore (Trivandrum, India)
Retinal Pathology in Parkinson’s Disease: A Longitudinal Study with Optical Coherence Tomography

F. Euler, D. Batra, J. Kassubek, E. Pinkhardt (Ulm, Germany)
Retinal thinning and disease worsening in Lewy body diseases

A. Murueta-Goyena, R. Del Pino, M. Galdós, B. Arana, M. Acera, MM. Carmona-Abellán, P. Reyero, B. Tijero, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, N. Ojeda, J. Peña, J.C Gómez-Esteban, I. Gabilondo (Barakaldo, Spain)
Retrospective review of MRI guided focused ultrasound thalamotomy referrals: experience from a single neuromodulation center

L. Pan, M. Banvard, A. Mogilner, M. Pourfar (New York, NY, USA)
Rhythmic activity of subthalamic neurons during externally and internally generated movements in Parkinson’s disease

V. Filyushkina, E. Belova, S. Usova, V. Popov, A. Tomskiy, A. Sedov (Moscow, Russian Federation)
Rhythmic movements decompose in Parkinson’s disease with worse disease severity at low frequencies: akinesia or impaired ability to move more slowly than comfortable?

S. Israeli-Korn, A. Korakin, N. Vaadia, S. Hassin-Baer, J. Friedman (Tel Hashomer, Israel)
Right hemispheric β-amyloid deposition associates with freezing of gait in Parkinson’s disease

P. Kanel, M. Müller, K. Frey, N. Bohnen (Ann Arbor, MI, USA)
Risk Factors and Subtypes of Ischemic Stroke in Patients with Parkinson’s Disease

M. Burzhunova, N. Garabova (Moscow, Russian Federation)
Risk of Hospital Admission in Patients with Parkinson’s disease Associated Psychosis (1991-2010)

C. Stang, M. Hajeb, E. Camerucci, P. Turcano, A. Mullan, P. Martin, V. Abler, M. Splett, N. Rashid, J. Bower, M. Mielke, R. Savica (Rochester, MN, USA)
Risk of Suicidal Ideation After Deep Brain Stimulation Surgery in Patients with Parkinson’s Disease

A. Seritan, J. Parad, S. Wang, J. Ostrem, A.M Iosif (San Francisco, CA, USA)
Robotic Assisted Arm Training in Parkinson’s disease rehabilitation: A pilot study

R. Yadav, S. Shukla (Etawah, India)
ROI based Machine Learning Classification Model for Spinocerebellar Ataxia type 12

S. Agrawal, M. Narang, P. Pankaj, A. Srivastava, S. Kumaran, R. Agrawal (New Delhi, India)
Role of Sex in Parkinson’s Disease Progression

E. Bayram, S. Eberly, D. Oakes, I. Litvan (La Jolla, CA, USA)
Rotenone exposure is associated with mitochondrial DNA (mtDNA) damage in humans

S. Goldman, C. Tanner, C. Gonzalez-Hunt, C. Meng, K. Comyns, M. Korell, L. Sanders (San Francisco, CA, USA)

Jump to: View All • a b c d e f g h i j k l m n o p q [r] s t u v w x y z